StockWatch
·
SHARDA MOTOR INDUSTRIES · Q2 FY27 · PREVIEW

Can Sharda Motor stabilise margins in Q2? Margin compression shadow over strong topline growth

After Q1's 34% revenue surge and 13% PAT fall, investors will watch whether the auto-ancillary is re-gaining pricing power or if cost pressures persist. New Haridwar plant and emission-norm tailwinds in play; Street sees upside.

Q2 FY27 resultsSHARDAMOTRSharda Motor Industries Ltd11 Nov 2026 · 3 min read

The Setup: Topline Wins, Margins Under Siege

Sharda Motor enters Q2 FY27 riding momentum from a 34% YoY revenue surge in Q1, but the earnings print told a darker story: consolidated PAT fell 13% YoY despite the growth. The culprit was margin compression—EBITDA contracted even as gross profit inched up, a classic cost-pressure signal. On result day (Nov 12), the Street will focus on whether the company is reclaiming pricing discipline or if Q2 reprises the squeeze.

Consolidated revenue (expected)

~₹1,050–1,100 Cr

on-plan +25–30% YoY; Q1 was +34%, so moderation possible but still strong

EBITDA margin (watch)

~11–12%

FY26 full-year was 12.3%; Q1 compression likely drove below that; stabilisation is the key

PAT (swing factor)

₹75–85 Cr

dependent entirely on margin recovery vs. Q1's -13% YoY fall; breakeven on volume growth

FII ownership

1.73%

down 0.7pp QoQ; DIIs steady; promoter locked at 64.31%

A strong Q2 would show revenue at or above ₹1,050 Cr (on-plan +25–30% YoY) and EBITDA margin stable or recovering toward 12–12.5%, with PAT in the ₹80–85 Cr range and positive YoY delta. A weak print would be revenue momentum faltering below +20% YoY, EBITDA margin sliding further into 10–11%, and PAT remaining flat or negative YoY, signalling persistent input cost or competitive pricing headwinds.

On-Track Check: Full-Year Guidance & Trajectory

Management has not issued explicit full-year FY27 guidance, so the read rests on trajectory. Q1's +34% revenue and +5% adjusted PAT suggest the company is tracking for mid-to-high double-digit revenue growth year-on-year, but the margin compression is a red flag. If Q2 stabilises EBITDA margin and PAT re-accelerates, the narrative is "cost pressures were Q1-temporary." If margins remain compressed, the story shifts to structural cost inflation or mix pressure (higher engineering content / lower-margin OEM work). The new Haridwar plant—licensed Oct 14—adds a capex overhang into H2; management will likely flag investment phasing on the call.

What the Street Says

Since Last Quarter: Filing Scan

Recent corporate filings and events (Oct 1 – Nov 9, 2026)

Oct 21

Event

Dividend withheld (KYC issue)

Signal

Routine admin; no operational impact

Oct 15

Event

Haridwar plant factory license issued

Signal

Positive — greenfield capex on track; production capacity expansion underway

Oct 1

Event

Trading window closed (Q2 results pre-announcement)

Signal

Routine — no insider trading signalled

Sep 24

Event

41st AGM held; FY26 BRSR filed

Signal

Routine governance; ESG disclosures current

The Haridwar plant license is the material operational event: it signals management's conviction in growth and willingness to fund capex into margin-pressure cycles. This is a multi-year bet on export and domestic volume, not a near-term earnings tailwind. FII selling (-0.7pp QoQ) is modest but worth watching; DIIs and promoters remain steady.

Key Risks / Watch Items

On result day and the call, watch for:
  • 1 · Margin trajectory clarity

    Is Q2 EBITDA margin stable vs. Q1, or sliding further? If recovery, by how much? This dominates the market re-rate.

  • 2 · Capex phasing & H2 outlook

    Management will update on Haridwar plant spending, timeline, and capacity ramp. Any guidance on FY27 capex intensity and its impact on FCF?

  • 3 · Volume mix commentary

    Is the revenue growth coming from higher volumes or better pricing? Mix towards lower-margin tiers vs. specialist products? This explains margin pressure.

  • 4 · Emission norms / customer wins

    Any updates on TREM V / BS 7 readiness? New customer scoops or export traction? OEM de-risking?

  • 5 · FII / promoter activity

    FII ownership has ticked down. Watch for any pledges or promoter moves post-result; thin public float is a structural concern.

Sharda Motor's Q2 result hangs on a single axis: margin stabilisation. The topline story—30%+ growth driven by domestic auto demand and the new Haridwar plant investment—is intact. But Q1's 13% PAT fall amid revenue surge signals cost headwinds (input inflation, competitive pricing, or mix) that must reverse or flatten in Q2 for the bull case to hold. Analyst consensus sits at ₹1,170–₹1,288, implying near-term upside, but that assumes H2 margin recovery and capex digestion. A weak PAT print or guidance miss on margin recovery could re-price the stock sharply, as the valuation embed is already pricing for a rebound. Watch the EBITDA margin card most closely; everything else flows from it.

Informational and educational content only. Not investment advice.